Diet, inflammation, and glycemic control in type 2 diabetes

An integrative review of the literature

Research output: Contribution to journalArticle

Abstract

Type 2 diabetes (T2D) is a growing national health problem affecting 35% of adults ≥20 years of age in the United States. Recently, diabetes has been categorized as an inflammatory disease, sharing many of the adverse outcomes as those reported from cardiovascular disease. Medical nutrition therapy is recommended for the treatment of diabetes; however, these recommendations have not been updated to target the inflammatory component, which can be affected by diet and lifestyle. To assess the current state of evidence for which dietary programs contain the most anti-inflammatory and glycemic control properties for patients with T2D, we conducted an integrative review of the literature. A comprehensive search of the PubMed, CINAHL, Scopus, and Web of Science databases from January 2000 to May 2012 yielded 786 articles. The final 16 studies met the selection criteria including randomized control trials, quasiexperimental, or cross-sectional studies that compared varying diets and measured inflammatory markers. The Mediterranean and DASH diets along with several low-fat diets were associated with lower inflammatory markers. The Mediterranean diet demonstrated the most clinically significant reduction in glycosylated hemoglobin (HbA 1c). Information on best dietary guidelines for inflammation and glycemic control in individuals with T2D is lacking. Continued research is warranted.

Original languageEnglish (US)
Article number542698
JournalJournal of Nutrition and Metabolism
Volume2012
DOIs
StatePublished - 2012

Fingerprint

glycemic control
noninsulin-dependent diabetes mellitus
Type 2 Diabetes Mellitus
Mediterranean Diet
Mediterranean diet
inflammation
Diet
Inflammation
diabetes
Dietary Approaches to Stop Hypertension diet
diet
Nutrition Therapy
Nutrition Policy
diet therapy
Fat-Restricted Diet
Dietary Guidelines
low fat diet
Glycosylated Hemoglobin A
selection criteria
PubMed

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Food Science
  • Nutrition and Dietetics

Cite this

@article{c94a7ef7fe114f00b9972e4e0c23c62a,
title = "Diet, inflammation, and glycemic control in type 2 diabetes: An integrative review of the literature",
abstract = "Type 2 diabetes (T2D) is a growing national health problem affecting 35{\%} of adults ≥20 years of age in the United States. Recently, diabetes has been categorized as an inflammatory disease, sharing many of the adverse outcomes as those reported from cardiovascular disease. Medical nutrition therapy is recommended for the treatment of diabetes; however, these recommendations have not been updated to target the inflammatory component, which can be affected by diet and lifestyle. To assess the current state of evidence for which dietary programs contain the most anti-inflammatory and glycemic control properties for patients with T2D, we conducted an integrative review of the literature. A comprehensive search of the PubMed, CINAHL, Scopus, and Web of Science databases from January 2000 to May 2012 yielded 786 articles. The final 16 studies met the selection criteria including randomized control trials, quasiexperimental, or cross-sectional studies that compared varying diets and measured inflammatory markers. The Mediterranean and DASH diets along with several low-fat diets were associated with lower inflammatory markers. The Mediterranean diet demonstrated the most clinically significant reduction in glycosylated hemoglobin (HbA 1c). Information on best dietary guidelines for inflammation and glycemic control in individuals with T2D is lacking. Continued research is warranted.",
author = "Nowlin, {Sarah Y.} and Marilyn Hammer and {D'Eramo Melkus}, Gail",
year = "2012",
doi = "10.1155/2012/542698",
language = "English (US)",
volume = "2012",
journal = "Journal of Nutrition and Metabolism",
issn = "2090-0724",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Diet, inflammation, and glycemic control in type 2 diabetes

T2 - An integrative review of the literature

AU - Nowlin, Sarah Y.

AU - Hammer, Marilyn

AU - D'Eramo Melkus, Gail

PY - 2012

Y1 - 2012

N2 - Type 2 diabetes (T2D) is a growing national health problem affecting 35% of adults ≥20 years of age in the United States. Recently, diabetes has been categorized as an inflammatory disease, sharing many of the adverse outcomes as those reported from cardiovascular disease. Medical nutrition therapy is recommended for the treatment of diabetes; however, these recommendations have not been updated to target the inflammatory component, which can be affected by diet and lifestyle. To assess the current state of evidence for which dietary programs contain the most anti-inflammatory and glycemic control properties for patients with T2D, we conducted an integrative review of the literature. A comprehensive search of the PubMed, CINAHL, Scopus, and Web of Science databases from January 2000 to May 2012 yielded 786 articles. The final 16 studies met the selection criteria including randomized control trials, quasiexperimental, or cross-sectional studies that compared varying diets and measured inflammatory markers. The Mediterranean and DASH diets along with several low-fat diets were associated with lower inflammatory markers. The Mediterranean diet demonstrated the most clinically significant reduction in glycosylated hemoglobin (HbA 1c). Information on best dietary guidelines for inflammation and glycemic control in individuals with T2D is lacking. Continued research is warranted.

AB - Type 2 diabetes (T2D) is a growing national health problem affecting 35% of adults ≥20 years of age in the United States. Recently, diabetes has been categorized as an inflammatory disease, sharing many of the adverse outcomes as those reported from cardiovascular disease. Medical nutrition therapy is recommended for the treatment of diabetes; however, these recommendations have not been updated to target the inflammatory component, which can be affected by diet and lifestyle. To assess the current state of evidence for which dietary programs contain the most anti-inflammatory and glycemic control properties for patients with T2D, we conducted an integrative review of the literature. A comprehensive search of the PubMed, CINAHL, Scopus, and Web of Science databases from January 2000 to May 2012 yielded 786 articles. The final 16 studies met the selection criteria including randomized control trials, quasiexperimental, or cross-sectional studies that compared varying diets and measured inflammatory markers. The Mediterranean and DASH diets along with several low-fat diets were associated with lower inflammatory markers. The Mediterranean diet demonstrated the most clinically significant reduction in glycosylated hemoglobin (HbA 1c). Information on best dietary guidelines for inflammation and glycemic control in individuals with T2D is lacking. Continued research is warranted.

UR - http://www.scopus.com/inward/record.url?scp=84873864025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873864025&partnerID=8YFLogxK

U2 - 10.1155/2012/542698

DO - 10.1155/2012/542698

M3 - Article

VL - 2012

JO - Journal of Nutrition and Metabolism

JF - Journal of Nutrition and Metabolism

SN - 2090-0724

M1 - 542698

ER -